Literature DB >> 15136694

Suggestive evidence for linkage to chromosome 13qter for autosomal dominant type 1 porencephaly.

U Aguglia1, A Gambardella, G J Breedveld, R L Oliveri, E Le Piane, D Messina, A Quattrone, P Heutink.   

Abstract

A large three-generation family with autosomal dominant type 1 porencephaly from southern Italy was studied. A high rate of miscarriages was observed. Of the nine affected individuals, four displayed a severe phenotype, and five had slight pyramidal signs or mild cognitive abnormalities. The MRI study disclosed unilateral porencephalic cyst, or colpocephaly. A genome-wide screen resulted in suggestive evidence for linkage to chromosome 13qter with a maximum logarithm-of-the-odds score of 3.16, from multipoint analysis, with marker D13S285.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15136694     DOI: 10.1212/01.wnl.0000123113.46672.68

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  9 in total

1.  Normal immunofluorescence pattern of skin basement membranes in a family with porencephaly due to COL4A1 G749S mutation.

Authors:  Sara Gasparini; Antonio Qualtieri; Edoardo Ferlazzo; Vittoria Cianci; Alessandra Patitucci; Patrizia Spadafora; Umberto Aguglia
Journal:  Neurol Sci       Date:  2015-12-19       Impact factor: 3.307

Review 2.  The collagenopathies: review of clinical phenotypes and molecular correlations.

Authors:  Rebekah Jobling; Rohan D'Souza; Naomi Baker; Irene Lara-Corrales; Roberto Mendoza-Londono; Lucie Dupuis; Ravi Savarirayan; L Ala-Kokko; Peter Kannu
Journal:  Curr Rheumatol Rep       Date:  2014-01       Impact factor: 4.592

Review 3.  Genotype-phenotype correlations in pathology caused by collagen type IV alpha 1 and 2 mutations.

Authors:  Marion Jeanne; Douglas B Gould
Journal:  Matrix Biol       Date:  2016-10-26       Impact factor: 11.583

Review 4.  Stroke-related translational research.

Authors:  Louis R Caplan; Juan Arenillas; Steven C Cramer; Anne Joutel; Eng H Lo; James Meschia; Sean Savitz; Elizabeth Tournier-Lasserve
Journal:  Arch Neurol       Date:  2011-05-09

5.  Novel mutations in three families confirm a major role of COL4A1 in hereditary porencephaly.

Authors:  G Breedveld; I F de Coo; M H Lequin; W F M Arts; P Heutink; D B Gould; S W M John; B Oostra; G M S Mancini
Journal:  J Med Genet       Date:  2005-08-17       Impact factor: 6.318

6.  Cerebrovascular disease related to COL4A1 mutations in HANAC syndrome.

Authors:  S Alamowitch; E Plaisier; P Favrole; C Prost; Z Chen; T Van Agtmael; B Marro; P Ronco
Journal:  Neurology       Date:  2009-12-01       Impact factor: 9.910

Review 7.  Mammalian collagen IV.

Authors:  Jamshid Khoshnoodi; Vadim Pedchenko; Billy G Hudson
Journal:  Microsc Res Tech       Date:  2008-05       Impact factor: 2.769

8.  Neurologic phenotypes associated with COL4A1/2 mutations: Expanding the spectrum of disease.

Authors:  Sara Zagaglia; Christina Selch; Jelena Radic Nisevic; Davide Mei; Zuzanna Michalak; Laura Hernandez-Hernandez; S Krithika; Katharina Vezyroglou; Sophia M Varadkar; Alexander Pepler; Saskia Biskup; Miguel Leão; Jutta Gärtner; Andreas Merkenschlager; Michaela Jaksch; Rikke S Møller; Elena Gardella; Britta Schlott Kristiansen; Lars Kjærsgaard Hansen; Maria Stella Vari; Katherine L Helbig; Sonal Desai; Constance L Smith-Hicks; Naomi Hino-Fukuyo; Tiina Talvik; Rael Laugesaar; Pilvi Ilves; Katrin Õunap; Ingrid Körber; Till Hartlieb; Manfred Kudernatsch; Peter Winkler; Mareike Schimmel; Anette Hasse; Markus Knuf; Jan Heinemeyer; Christine Makowski; Sondhya Ghedia; Gopinath M Subramanian; Pasquale Striano; Rhys H Thomas; Caroline Micallef; Maria Thom; David J Werring; Gerhard Josef Kluger; J Helen Cross; Renzo Guerrini; Simona Balestrini; Sanjay M Sisodiya
Journal:  Neurology       Date:  2018-11-09       Impact factor: 9.910

Review 9.  COL4A1 and COL4A2 mutations and disease: insights into pathogenic mechanisms and potential therapeutic targets.

Authors:  Debbie S Kuo; Cassandre Labelle-Dumais; Douglas B Gould
Journal:  Hum Mol Genet       Date:  2012-08-21       Impact factor: 6.150

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.